Page last updated: 2024-09-03

pentosidine and olmesartan medoxomil

pentosidine has been researched along with olmesartan medoxomil in 2 studies

Compound Research Comparison

Studies (pentosidine)	Trials (pentosidine)	Recent Studies (post-2010) (pentosidine)	Studies (olmesartan medoxomil)	Trials (olmesartan medoxomil)	Recent Studies (post-2010) (olmesartan medoxomil)
577	34	205	459	119	203

Protein Interaction Comparison

Protein	Taxonomy	olmesartan medoxomil (IC50)
ATP-binding cassette sub-family C member 3	Homo sapiens (human)	2
Bile salt export pump	Homo sapiens (human)	4.73
Solute carrier organic anion transporter family member 1B3	Homo sapiens (human)	0.9772
Solute carrier organic anion transporter family member 1B1	Homo sapiens (human)	0.9772

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H	1
Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T	1

Trials

1 trial(s) available for pentosidine and olmesartan medoxomil

Article	Year
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients. Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome	2012

Article

Year

Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome

2012

Other Studies

1 other study(ies) available for pentosidine and olmesartan medoxomil

Article	Year
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:5 Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles	2003

Article

Year

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.

Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:5

Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles

2003